Finally, our in vitro studies showed that IFNβ suppressed TNFα+tPA-induced inflammatory molecules, IL-1α and IL-1β, and enhanced anti-inflammatory molecules, Arg1 and CD206, in primary MG, consistent with our in vivo findings. The gene discussed is ARG1; the disease is myasthenia gravis.